Here, we identified a novel population of bone marrow stromal cells with osteoblast-chondrocyte transitional (OCT) identities in the endosteum, which are abundant in young stages and coordinate active bone formation; these cells can also be converted into osteosarcoma-forming cells upon loss of the p53 tumor suppressor. Here, TP53 is linked to osteosarcoma.